Related Experiment Video
Updated: Dec 28, 2025

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Optimizing Communication About Topical Corticosteroids: A Quality Improvement Study
Valérie Johnson Girard1, Ashley Hill2, Emma Glaser3
159429 Department of Medicine (Dermatology), Hôpital de la Cité-de-la-Santé, Laval, Centre intégré de santé et des services sociaux de Laval, Quebec, Canada.
Improving dermatologist-patient communication about topical corticosteroids (TCS) can enhance adherence. An educational intervention increased discussions on patient experiences and concerns, though patient input remained limited.
Area of Science:
- Dermatology
- Medical Communication
- Quality Improvement
Background:
- Patient non-adherence to topical corticosteroids (TCS) is a significant clinical challenge.
- Poor communication between dermatologists and patients may contribute to TCS non-adherence.
Purpose of the Study:
- To describe dermatologist-patient communication patterns regarding TCS treatments.
- To compare communication before and after implementing an educational intervention.
Main Methods:
- A quality improvement study involving audiotaped encounters between dermatologists and new outpatients receiving TCS prescriptions.
- An intervention comprising a patient educational pamphlet and a dermatology team communication workshop.
- Communication analysis using the MEDICODE system, comparing pre- and post-intervention phases.
Main Results:
- Pre-intervention, dermatologists frequently discussed medication information but rarely patient experience themes (e.g., treatment goals, adverse effects, patient emotions).
- Post-intervention, discussion of patient experience themes increased without extending consultation length.
- In both phases, communication was largely monologistic, with limited patient verbal input.
Conclusions:
- The study highlights areas for improving dermatologist communication regarding TCS, particularly concerning adverse effects and patients' emotional responses.
- Enhanced communication is crucial for improving patient understanding and adherence to TCS treatments.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Dosage Regimens: Designs and Approaches
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids